Give 15% off, earn 10% back on every order they place.
Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.

Delivers to EU in 11-14 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade Follistatin 344. ≥98% (supplier batch specification); selected lots independently tested by Janoshik (HPLC + mass spectrometry), searchable at certapeptides.com/verify. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
MADE TO ORDER — Expected delivery: ~3 weeks
Synthesized after your order is placed. We'll email you tracking details when it ships.
This product is being restocked
We're working with our supplier to restock this item. Sign up below to be the first to know, or save it to your wishlist.
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
Reconstitution Required
This peptide ships lyophilized (dry powder) and requires bacteriostatic water to reconstitute before use. BAC water is sold separately.
99.3% average HPLC purity, verified by independent third-party testing
Janoshik report published when available
24h dispatch, EU-wide shipping from €4.99
Supplier batch specification on every product; independent Janoshik report on selected lots
Follistatin 344 is the predominant isoform of follistatin expressed in most non-gonadal tissues. Follistatin is an activin-binding protein that was originally identified as an FSH-suppressing factor but has much broader biology -- it binds and neutralizes several TGF-beta superfamily members including activin A, BMP-2, BMP-4, BMP-7, and, critically for muscle research, myostatin. By neutralizing myostatin (GDF-8), follistatin is studied as a pro-hypertrophic factor in skeletal muscle research models. Each vial contains 1mg.
Myostatin is the primary negative regulator of myogenesis-pathway activity in mammals. Myostatin loss-of-function is associated with increased muscle mass across animal models such as mice, cattle, and dogs in published research. Follistatin's ability to neutralize myostatin has made it one of the most studied pro-muscular factors in research contexts. Importantly, follistatin works upstream of the receptor -- it sequesters myostatin before it can bind ActRIIB -- which is a different mechanism from ActRIIB antagonists that block the receptor directly.
Follistatin-344 vs Follistatin-288: the difference is in the C-terminal tail. FS288 (the heparan sulfate-binding form) stays localized to tissues; FS344 circulates more freely and has longer systemic activity. In research targeting circulating myostatin, the full-length FS344 variant is commonly studied. For local tissue studies, FS288 may be more appropriate.
| Parameter | Value |
|---|---|
| Compound | Follistatin 344 (FS344 isoform) |
| Amount per Vial | 1mg |
| Purity | ≥98% (supplier batch specification); selected lots independently tested by Janoshik (HPLC + mass spectrometry), searchable at certapeptides.com/verify |
| Format | Lyophilized powder |
| Reconstitution | Sterile PBS or 0.1% BSA in PBS |
| Storage | -20°C; 2-8°C after reconstitution |
Store at -20°C before reconstitution. Follistatin is a glycoprotein -- reconstitute with sterile PBS or BSA-containing buffer to prevent adsorption to tube surfaces. Refrigerate after reconstitution and use within 7-14 days.
Myostatin (GDF-8) is a TGF-beta family member that suppresses muscle satellite cell proliferation and muscle protein synthesis -- it is the primary brake on myogenesis-pathway activity in mammals. Follistatin binds myostatin with high affinity and neutralizes it before it can activate its receptor (ActRIIB). This effectively removes the inhibitory signal, allowing satellite cell proliferation and muscle hypertrophy to proceed without the myostatin constraint. The dramatic muscle development seen in myostatin knockout animals represents the upper limit of this effect.
The two isoforms differ in their C-terminal tails. Follistatin-288 has a tail that binds heparan sulfate proteoglycans in the extracellular matrix, anchoring it to local tissue. Follistatin-344 has a longer tail that reduces heparan sulfate binding and allows it to circulate more freely. In research targeting circulating myostatin, the FS344 variant is commonly studied. For studies of local effects in specific tissues, FS288's tissue localization may be more appropriate. Most research literature and muscle-focused studies use FS344.
Follistatin binds multiple TGF-beta superfamily members: activin A and B (the original discovery context, relevant to FSH regulation and reproductive biology), BMP-2, BMP-4, BMP-7, and BMP-11 (GDF-11). This broad binding profile means follistatin administration affects multiple signaling pathways beyond just myostatin. For research where myostatin inhibition specifically is the goal, this promiscuity should be accounted for in interpretation. Compounds that specifically block ActRIIB or target myostatin directly (like anti-myostatin antibodies) have narrower activity if target specificity is critical.
Follistatin 344 is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Researcher Confidence
Who actually tests this?
Selected lots are independently verified by Janoshik Analytical (Czech Republic) and published on the Janoshik public portal. Other lots ship with the supplier's batch specification. See /coa for the published wall.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI 54169956, VAT-registered. Sameday for Romania, TCE Worldwide for all cross-border EU and non-EU markets (UK, Switzerland, Norway, Iceland, Israel, Serbia). Delivery 1–14 business days depending on destination — exact window shown at checkout.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
18mgSAME FIELDResearch-grade Tesamorelin + Ipamorelin Blend. Each vial contains 9mg Tesamorelin + 9mg Ipamorelin (1:1 ratio, 18mg total). ≥ 98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
SAME FIELDIGF-1 LR3 (Long Arg3 IGF-1) is an 83-amino acid analog of insulin-like growth factor 1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. These modifications significantly reduce IGF binding protein affinity, increasing bioavailability in research applications. Extended analog of IGF-1 with enhanced bioavailability Muscle hypertrophy and tissue growth studies IGF-1 signaling pathway and receptor activation research For research purposes only.
SAME FIELDResearch-grade AOD-9604. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
RESEARCHERS ALSO STUDIEDResearch-grade CJC-1295 Without DAC. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial.